BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28325522)

  • 21. Do we have a less severe form of Kawasaki disease or is it the gammaglobulin effect?
    Abushaban L; Salama A; Uthaman B; Kumar A; Selvan J
    Int J Cardiol; 1999 Apr; 69(1):71-6. PubMed ID: 10362375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary artery aneurysm regression after Kawasaki disease and associated risk factors: a 3-year follow-up study in East China.
    Tang Y; Yan W; Sun L; Xu Q; Ding Y; Lv H
    Clin Rheumatol; 2018 Jul; 37(7):1945-1951. PubMed ID: 29330741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.
    Liu MY; Liu HM; Wu CH; Chang CH; Huang GJ; Chen CA; Chiu SN; Lu CW; Lin MT; Chang LY; Wang JK; Wu MH
    BMC Pediatr; 2017 Jun; 17(1):139. PubMed ID: 28587647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors associated with progression and persistence of small- and medium-sized coronary artery aneurysms in Kawasaki disease: a prospective cohort study.
    Liu L; Luo C; Hua Y; Wu M; Shao S; Liu X; Zhou K; Wang C
    Eur J Pediatr; 2020 Jun; 179(6):891-900. PubMed ID: 31980953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissecting Kawasaki disease: a state-of-the-art review.
    Dietz SM; van Stijn D; Burgner D; Levin M; Kuipers IM; Hutten BA; Kuijpers TW
    Eur J Pediatr; 2017 Aug; 176(8):995-1009. PubMed ID: 28656474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
    Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary adjunctive corticosteroid therapy is associated with improved outcomes for patients with Kawasaki disease with coronary artery aneurysms at diagnosis.
    Friedman KG; Gauvreau K; Baker A; Son MB; Sundel R; Dionne A; Giorgio T; De Ferranti S; Newburger JW
    Arch Dis Child; 2021 Mar; 106(3):247-252. PubMed ID: 32943389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
    Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm.
    Peng Y; Cheng Z; Yi Q
    Clin Exp Med; 2023 Aug; 23(4):1317-1324. PubMed ID: 36151486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying Kawasaki Disease With a Low Coronary Artery Aneurysm Risk.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    Pediatr Infect Dis J; 2023 Jul; 42(7):608-613. PubMed ID: 37053581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment and Coronary Artery Aneurysm Formation in Kawasaki Disease: A Per-Day Risk Analysis.
    van Stijn D; Korbee JM; Netea SA; de Winter VC; Zwinderman KAH; Kuipers IM; Kuijpers TW
    J Pediatr; 2022 Apr; 243():167-172.e1. PubMed ID: 34968497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey.
    Sudo D; Monobe Y; Yashiro M; Sadakane A; Uehara R; Nakamura Y
    Pediatr Int; 2010 Oct; 52(5):790-4. PubMed ID: 20487371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Kawasaki disease using locally product intravenous immunoglobulin.
    Sangtawesin C; Kirawitaya T; Layangkool T; Nawasiri W; Vimolsarawong N
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S656-60. PubMed ID: 14700163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
    Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.
    Tajima M; Shiozawa Y; Kagawa J
    Pediatr Cardiol; 2015 Aug; 36(6):1159-65. PubMed ID: 25753685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Presentation and Outcomes of Kawasaki Disease in Children from Latin America: A Multicenter Observational Study from the REKAMLATINA Network.
    Narayan HK; Lizcano A; Lam-Hine T; Ulloa-Gutierrez R; Bainto EV; Garrido-García LM; Estripeaut D; Del Aguila O; Gómez V; Faugier-Fuentes E; Miño-León G; Beltrán S; Cofré F; Chacon-Cruz E; Saltigeral-Simental P; Martínez-Medina L; Dueñas L; Luciani K; Rodríguez-Quiroz FJ; Camacho Moreno G; Viviani T; Alvarez-Olmos MI; Marques HHS; López-Medina E; Pirez MC; Tremoulet AH;
    J Pediatr; 2023 Dec; 263():113346. PubMed ID: 36775190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline
    Son MBF; Gauvreau K; Kim S; Tang A; Dedeoglu F; Fulton DR; Lo MS; Baker AL; Sundel RP; Newburger JW
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population?
    Edraki MR; Mohammadi H; Mehdizadegan N; Ghorashi M; Amoozgar H; Borzouee M; Ajami G; Keshavarz K; Dehghani E; Bahrami R
    Arch Iran Med; 2020 Jan; 23(1):31-36. PubMed ID: 31910632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms.
    Halyabar O; Friedman KG; Sundel RP; Baker AL; Chang MH; Gould PW; Newburger JW; Son MBF
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):31. PubMed ID: 33731148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.